UNEARTH RX Trademark

Trademark Overview


On Monday, February 5, 2024, a trademark application was filed for UNEARTH RX with the United States Patent and Trademark Office. The USPTO has given the UNEARTH RX trademark a serial number of 98391202. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, December 18, 2025. This trademark is owned by Kapoose Creek Bio Corp.. The UNEARTH RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and analysis; biomedical research; chemical analysis; chemical research; consulting services in the field of pharmaceutical research; drug discovery services; drug screening for scientific research purposes; executing of chemical analyses; industrial analysis and research services in the field of agriculture and horticulture; medical research; pharmacological research services; medical research; research and design in the field of chemistry; research and development of new products for others; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the field of biochemistry; testing of new products for others; medical and pharmaceutical research and development services in the field of mycology; medical and pharmaceutical research and development services utilizing artificial intelligence and machine learning; medical and pharmaceutical research and development services utilizing phenotypic screen...
unearth rx

General Information


Serial Number98391202
Word MarkUNEARTH RX
Filing DateMonday, February 5, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, December 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiochemical research and analysis; biomedical research; chemical analysis; chemical research; consulting services in the field of pharmaceutical research; drug discovery services; drug screening for scientific research purposes; executing of chemical analyses; industrial analysis and research services in the field of agriculture and horticulture; medical research; pharmacological research services; medical research; research and design in the field of chemistry; research and development of new products for others; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the field of biochemistry; testing of new products for others; medical and pharmaceutical research and development services in the field of mycology; medical and pharmaceutical research and development services utilizing artificial intelligence and machine learning; medical and pharmaceutical research and development services utilizing phenotypic screening; phenotypic screening analysis in the field of mycology drug discovery services utilizing artificial intelligence and machine learning for discovering novel molecules to develop into drug compounds; providing online non-downloadable software for recommending chemical compounds based on artificial intelligence and machine learning
NOT AVAILABLERX

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 5, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKapoose Creek Bio Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6H3Y4
CA

Trademark Events


Event DateEvent Description
Monday, February 5, 2024NEW APPLICATION ENTERED
Sunday, June 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 28, 2024ASSIGNED TO EXAMINER
Monday, October 7, 2024NON-FINAL ACTION WRITTEN
Monday, October 7, 2024NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 6, 2025SUSPENSION LETTER WRITTEN
Thursday, February 6, 2025LETTER OF SUSPENSION E-MAILED
Thursday, February 6, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 7, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, October 6, 2025SUSPENSION INQUIRY WRITTEN
Monday, October 6, 2025INQUIRY TO SUSPENSION E-MAILED
Monday, October 6, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, December 10, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 18, 2025ASSIGNED TO LIE
Thursday, December 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 18, 2025SUSPENSION LETTER WRITTEN
Thursday, December 18, 2025LETTER OF SUSPENSION E-MAILED
Thursday, December 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED